Sanaby Health Acquisition Corp. I
General Information | |
Business: | We intend to capitalize on our management team’s ability to identify, acquire and manage a business that can capitalize on the operational expertise of our management team across a diverse array of healthcare-related industries – with a specific focus on digital health, life science tools and services, and innovative treatment developers. Sandra Shpilberg is our CEO. She is a serial entrepreneur, biotech executive and active investor, with M&A experience. In 2015, Shpilberg founded Seeker Health®, a breakthrough patient-finding platform. The company grew rapidly to serve 60+ biopharmaceutical companies with clinical trial enrollment. In 2018, EVERSANA®, a large life sciences services conglomerate, acquired Seeker Health for an undisclosed sum. Morgan Stanley recognized Seeker Health as a Healthcare Innovator in its 2019 report “Incubators of Innovation: The Role of Private Companies in Healthcare.” (Note: Sanaby Health Acquisition Corp. I priced its SPAC IPO on Oct. 14, 2021, in line with its prospectus: 15 million shares at $10 each to raise $150 million.) |
Industry: | BLANK CHECKS |
Employees: | 0 |
Founded: | 2021 |
Contact Information | |
Address | 2625 Middlefield Road #990 Palo Alto, CA 94306 |
Phone Number | 415-580-1810 |
Web Address | |
View Prospectus: | Sanaby Health Acquisition Corp. I |
Financial Information | |
Market Cap | $195.0mil |
Revenues | $0 mil (last 12 months) |
Net Income | $0 mil (last 12 months) |
IPO Profile | |
Symbol | SANBU |
Exchange | NASDAQ |
Shares (millions): | 15.0 |
Price range | $10.00 - $10.00 |
Est. $ Volume | $150.0 mil |
Manager / Joint Managers | BTIG |
CO-Managers | I-Bankers Securities |
Expected To Trade: | 10/15/2021 |
Status: | Priced |
Quiet Period Expiration Date: | Available only to Subscribers |
Lock-Up Period Expiration Date: | Available only to Subscribers |
SCOOP Rating | Available only to Subscribers |
Rating Change | Available only to Subscribers |